{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:42:14Z","timestamp":1790199734708,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.urolonc.2012.01.011","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T00:01:42Z","timestamp":1335225702000},"page":"1171-1177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists"],"prefix":"10.1016","volume":"31","author":[{"given":"Farshid","family":"Dayyani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis A.","family":"Pettaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Munsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanishka","family":"Sircar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance C.","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2012.01.011_bib1","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA: J Clin"},{"key":"10.1016\/j.urolonc.2012.01.011_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1442-2042.2002.00500.x","article-title":"Survey of incidence of urological cancer in South Korea: a 15-year summary","volume":"9","author":"Cheon","year":"2002","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2012.01.011_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0094-0143(21)00401-8","article-title":"The role of radiation therapy in the management of carcinoma of the male and female urethra","volume":"19","author":"Forman","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2012.01.011_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0094-0143(21)00398-0","article-title":"Carcinoma of the male and female urethra","volume":"19","author":"Mostofi","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2012.01.011_bib5","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.urology.2006.08.1057","article-title":"Incidence of primary urethral carcinoma in the United States","volume":"68","author":"Swartz","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.01.011_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0090-4295(94)90242-9","article-title":"Therapy and prognosis for male anterior urethral carcinoma: an update","volume":"43","author":"Dinney","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2012.01.011_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1442-2042.2006.01392.x","article-title":"Clinical outcome of 36 male patients with primary urethral carcinoma: a single center experience","volume":"13","author":"Thyavihally","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2012.01.011_bib8","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1200\/JCO.2002.11.114","article-title":"Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma","volume":"20","author":"Pagliaro","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2012.01.011_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1586\/14737140.6.6.877","article-title":"Systemic chemotherapy options for metastatic bladder cancer","volume":"6","author":"Siefker-Radtke","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.urolonc.2012.01.011_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat, American Statistical Assoc"},{"key":"10.1016\/j.urolonc.2012.01.011_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J Royal Stat Soc: B (Statistical Methodology)"},{"key":"10.1016\/j.urolonc.2012.01.011_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.juro.2007.09.068","article-title":"Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra","volume":"179","author":"Cohen","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.011_bib13","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/S0022-5347(05)65669-8","article-title":"Results of high dose rate brachytherapy, anterior pelvic exenteration, and external beam radiotherapy for carcinoma of the female urethra","volume":"166","author":"Dalbagni","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2012.01.011_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0090-4295(98)00199-X","article-title":"Management of primary urethral cancer","volume":"52","author":"Gheiler","year":"1998","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912000415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143912000415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:12:28Z","timestamp":1786450348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143912000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1078143912000415"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.01.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2012.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}